FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008744375> ?p ?o ?g. }

• W3008744375 endingPage "1757" @default.
• W3008744375 startingPage "1757" @default.
• W3008744375 abstract "Myotonic dystrophy type 1 (DM1) is a spliceopathy related to the mis-splicing of several genes caused by sequestration of nuclear transcriptional RNA-binding factors from non-coding CUG repeats of DMPK pre-mRNAs. Dysregulation of ryanodine receptor 1 (RYR1), sarcoplasmatic/endoplasmatic Ca2+-ATPase (SERCA) and α1S subunit of voltage-gated Ca2+ channels (Cav1.1) is related to Ca2+ homeostasis and excitation-contraction coupling impairment. Though no pharmacological treatment for DM1 exists, aberrant splicing correction represents one major therapeutic target for this disease. Resveratrol (RES, 3,5,4′-trihydroxy-trans-stilbene) is a promising pharmacological tools for DM1 treatment for its ability to directly bind the DNA and RNA influencing gene expression and alternative splicing. Herein, we analyzed the therapeutic effects of RES in DM1 myotubes in a pilot study including cultured myotubes from two DM1 patients and two healthy controls. Our results indicated that RES treatment corrected the aberrant splicing of RYR1, and this event appeared associated with restoring of depolarization-induced Ca2+ release from RYR1 dependent on the electro-mechanical coupling between RYR1 and Cav1.1. Interestingly, immunoblotting studies showed that RES treatment was associated with a reduction in the levels of CUGBP Elav-like family member 1, while RYR1, Cav1.1 and SERCA1 protein levels were unchanged. Finally, RES treatment did not induce any major changes either in the amount of ribonuclear foci or sequestration of muscleblind-like splicing regulator 1. Overall, the results of this pilot study would support RES as an attractive compound for future clinical trials in DM1. Ethical approval was obtained from the Ethical Committee of IRCCS Fondazione Policlinico Universitario A. Gemelli, Rome, Italy (rs9879/14) on May 20, 2014." @default.
• W3008744375 created "2020-03-06" @default.
• W3008744375 creator A5007007162 @default.
• W3008744375 creator A5024044785 @default.
• W3008744375 creator A5028478505 @default.
• W3008744375 creator A5032314426 @default.
• W3008744375 creator A5035300651 @default.
• W3008744375 creator A5036926288 @default.
• W3008744375 creator A5037098935 @default.
• W3008744375 creator A5064387688 @default.
• W3008744375 date "2020-01-01" @default.
• W3008744375 modified "2023-10-03" @default.
• W3008744375 title "Resveratrol corrects aberrant splicing of RYR1 pre-mRNA and Ca²⁺ signal in myotonic dystrophy type 1 myotubes" @default.
• W3008744375 cites W1527378180 @default.
• W3008744375 cites W1555409852 @default.
• W3008744375 cites W1906824575 @default.
• W3008744375 cites W1971507786 @default.
• W3008744375 cites W1974150730 @default.
• W3008744375 cites W1980729692 @default.
• W3008744375 cites W2013141604 @default.
• W3008744375 cites W2016866962 @default.
• W3008744375 cites W2021259180 @default.
• W3008744375 cites W2026657651 @default.
• W3008744375 cites W2047069685 @default.
• W3008744375 cites W2048359227 @default.
• W3008744375 cites W2049400321 @default.
• W3008744375 cites W2068816428 @default.
• W3008744375 cites W2072231551 @default.
• W3008744375 cites W2074716800 @default.
• W3008744375 cites W2078023359 @default.
• W3008744375 cites W2081280332 @default.
• W3008744375 cites W2081748748 @default.
• W3008744375 cites W2081918359 @default.
• W3008744375 cites W2088355928 @default.
• W3008744375 cites W2090638787 @default.
• W3008744375 cites W2093108716 @default.
• W3008744375 cites W2094886322 @default.
• W3008744375 cites W2096264344 @default.
• W3008744375 cites W2101175162 @default.
• W3008744375 cites W2102145465 @default.
• W3008744375 cites W2109436341 @default.
• W3008744375 cites W2113675895 @default.
• W3008744375 cites W2113918626 @default.
• W3008744375 cites W2114651629 @default.
• W3008744375 cites W2115880533 @default.
• W3008744375 cites W2116468636 @default.
• W3008744375 cites W2122522202 @default.
• W3008744375 cites W2123356145 @default.
• W3008744375 cites W2128578017 @default.
• W3008744375 cites W2130730649 @default.
• W3008744375 cites W2133444149 @default.
• W3008744375 cites W2134653802 @default.
• W3008744375 cites W2154540873 @default.
• W3008744375 cites W2156684483 @default.
• W3008744375 cites W2162198641 @default.
• W3008744375 cites W2164844447 @default.
• W3008744375 cites W2171805190 @default.
• W3008744375 cites W2282578375 @default.
• W3008744375 cites W2334464422 @default.
• W3008744375 cites W2408350377 @default.
• W3008744375 cites W2467076016 @default.
• W3008744375 cites W2524790117 @default.
• W3008744375 cites W2575902933 @default.
• W3008744375 cites W2583498826 @default.
• W3008744375 cites W2593652049 @default.
• W3008744375 cites W2616398857 @default.
• W3008744375 cites W2810959734 @default.
• W3008744375 cites W2913081176 @default.
• W3008744375 cites W2979342012 @default.
• W3008744375 doi "https://doi.org/10.4103/1673-5374.276336" @default.
• W3008744375 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7437583" @default.
• W3008744375 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32209783" @default.
• W3008744375 hasPublicationYear "2020" @default.
• W3008744375 type Work @default.
• W3008744375 sameAs 3008744375 @default.
• W3008744375 citedByCount "4" @default.
• W3008744375 countsByYear W30087443752021 @default.
• W3008744375 countsByYear W30087443752022 @default.
• W3008744375 crossrefType "journal-article" @default.
• W3008744375 hasAuthorship W3008744375A5007007162 @default.
• W3008744375 hasAuthorship W3008744375A5024044785 @default.
• W3008744375 hasAuthorship W3008744375A5028478505 @default.
• W3008744375 hasAuthorship W3008744375A5032314426 @default.
• W3008744375 hasAuthorship W3008744375A5035300651 @default.
• W3008744375 hasAuthorship W3008744375A5036926288 @default.
• W3008744375 hasAuthorship W3008744375A5037098935 @default.
• W3008744375 hasAuthorship W3008744375A5064387688 @default.
• W3008744375 hasBestOaLocation W30087443751 @default.
• W3008744375 hasConcept C104317684 @default.
• W3008744375 hasConcept C105580179 @default.
• W3008744375 hasConcept C113217602 @default.
• W3008744375 hasConcept C153911025 @default.
• W3008744375 hasConcept C185592680 @default.
• W3008744375 hasConcept C194583182 @default.
• W3008744375 hasConcept C207200792 @default.
• W3008744375 hasConcept C2776333580 @default.
• W3008744375 hasConcept C2778063965 @default.
• W3008744375 hasConcept C3763915 @default.

• next